Ultrasound for monitoring different stages of post-transplant lymphoproliferative disorder in a transplanted kidney: A case report and review of the literature

Zu-Sheng Du,Xiao-Hong Xie,Jin-Jiao Hu,Ye Fang,Lu Ye

DOI: https://doi.org/10.1097/md.0000000000036206

IF: 1.6

2024-02-25

Medicine

Abstract:Post-transplant lymphoproliferative disorder (PTLD) is a rare but severe complication of solid organ transplantation, which is frequently related to the infection of Epstein-Barr virus (EBV) and cytomegalovirus (CMV). [ 1 ] Only 1% of kidney transplant recipients will develop PTLD, which is substantially lower than other organ recipients. [ 2 , 3 ] Early detection and diagnosis of PTLD in transplanted kidneys are crucial for prognosis, enabling patients to receive treatment as soon as possible. [ 4 ] As the first-line imaging method for routine follow-up after kidney transplantation, ultrasound (US) has the advantages of convenience, non-invasiveness, and non-radiation, which has become an essential tool for discovering and differentiating substantive causes in transplanted kidneys. [ 5 ] With the development of US technology, the application of contrast-enhanced ultrasound (CEUS) in kidney transplantation is increasingly mature and extensive, which can display real-time microcirculation blood perfusion in transplanted kidney tissue with unique advantages such as good repeatability and no nephrotoxicity. CEUS provides a good prospect for early detection and diagnosis of postoperative complications and improvement of patient survival rate after kidney transplantation. [ 6 , 7 ]

medicine, general & internal